Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda takes the lead on Finch's ulcerative colitis candidate FIN-524

pharmatimesAugust 12, 2021

Tag: Takeda , Finch , FIN-524 , IBD

PharmaSources Customer Service